One ingredient

Is the Turmeric in ExiTide Strong Enough, and Is It Safe for the Liver?

What does the turmeric row on the ExiTide panel actually say?

The row reads “Turmeric Extract (Std. 95% Curcumin)” and the amount is 15 mg. Two facts sit inside that one line. The first is that the 15 mg is an extract, not ground root. The second is that the maker says 95% of the extract is curcumin.

A standardisation like this turns a name into arithmetic. Take 95% of 15 mg and you get about 14 mg of curcuminoids. Curcuminoids are the yellow pigments in the root, and curcumin is the best known of them.

It is also worth saying what a standardisation is. It tells you what the maker intends the material to hold. It is a specification, not a measurement of your bottle. NCCIH notes that oral curcumin products vary in how much curcumin they actually hold, and a printed percentage at least answers that question before it is asked.

How does 14 mg compare with what the studies used?

The curcumin paper cited on this site is a 2019 meta-analysis by Akbari and colleagues. It pooled 21 studies in 1,604 people. It found small drops in BMI, body weight and waist size. The curcuminoid amounts ran from 80 mg a day up to 1,890 mg, and the most common amount was about 1,000 mg a day.

Even the lowest amount in that review, 80 mg, is more than five times what the capsule carries. The most common amount is about seventy times higher. The capsule is not close to a studied amount.

That does not make the row a bad idea or a wrong label. It means the review cannot be quoted as support for one ExiTide capsule. NCCIH is blunter than most sellers would like: not enough is known, it says, to call curcumin beneficial for any health purpose.

This site makes no weight or disease claim of its own about turmeric. The bottle's support lines are the maker's wording, each marked with an asterisk that points to the FDA statement.

Does the turmeric in ExiTide carry the liver warning in the news?

This question deserves a careful answer in both directions. LiverTox is the NIH reference on drug-induced liver injury, and it rates turmeric A for likelihood. In plain words, it calls turmeric a well-documented cause of clinically apparent liver injury. No one should soften that.

The detail is what makes it usable. For a long time, nobody tied turmeric to liver injury. One reason offered was that curcumin is poorly absorbed by mouth. Later, makers found ways to raise absorption, such as adding piperine from black pepper or using lipid nanoparticles. The cases of liver injury were linked to those high-bioavailability forms of purified curcumin. NCCIH makes the same point in shorter form: highly bioavailable curcumin formulations may harm the liver.

On the ExiTide label the turmeric row is a 95% curcumin extract at 15 mg. The label names no piperine and no absorption-boosting delivery system. So the record is a warning about a category with a mechanism attached, not a finding about this capsule.

If you ever notice those signs while taking any supplement, stop it and speak to a doctor. Many people have a turmeric product somewhere at home already. The thing to check on that label is whether it advertises enhanced absorption, black pepper extract or piperine, and to tell your doctor if it does.

What are the label, price and guarantee facts?

Why is turmeric on the bottle but not on the listing graphic?

The seller's listing artwork shows six ingredients: riboflavin, mangosteen, prickly pear, cinnamon bark, konjac fibre and alpha lipoic acid. The printed label has eleven. Turmeric, berberine, resveratrol and both live cultures appear on the bottle and not on that graphic.

That is not a trick, and the panel is the stronger source. If you are comparing ExiTide with other products, compare the bottle panel, not the marketing picture. A listing that shows fewer rows than the label is a small flag, and it is better to know it than to find out later.

Who should be careful before taking it?

The bottle gives the plain rule. It says: do not exceed the recommended dose, do not use if under 18 or pregnant or nursing, and consult a physician first, especially if you take a medication or have a medical condition.

A few specific things follow from the turmeric record. If you already have a liver condition, or you take other turmeric or curcumin products, tell the prescriber before you add another. Bring the bottle to the appointment. A panel that names eleven ingredients with amounts is far more useful on a desk than the word supplement.

ExiTide is a dietary supplement. It is not a drug, and no dietary supplement is FDA approved.

What is not published about the turmeric row?

• The part of the plant used and the source of the extract are not printed.
• No assay result for this lot has been published. The lot code and certificate reference are markings on the label and not a laboratory report.
• No study of the finished capsule exists, so the effect of 14 mg of curcuminoids next to ten other rows is unknown.
• How long to keep taking it is not stated beyond the one-capsule-daily suggested use.

Frequently asked questions

Our view

The turmeric row is small, and the label does not hide that. It is standardised, which lets you do the sum yourself, and it carries no absorption booster, which matters for the liver record. Those are good signs for transparency.

They are not signs of a proven effect. The studies used far more, and the best summary from NCCIH is that not enough is known. If you enjoy the idea of a readable panel and you will judge the capsule over several weeks, the row is fine to accept. If you want trial-sized turmeric, buy a single-ingredient product and speak to your doctor about it.

Whatever you choose, keep medical questions with a clinician who knows your history.

Last updated October 16, 2026